9 Results for "

fecal output

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "fecal output" in MCE Product Catalog:

Cat. No.: HY-B1073
CAS No.: 26155-31-7
Target:  

Parasite

Research Areas:  

Infection

Morantel tartrate is an anthelmintic agent. Sustained-release three-layer composite tablets of Morantel tartrate are administered orally and release after exposure to rumen fluid. Morantel tartrate reduces the fecal egg output and worm burden of gastrointestinal nematodes in Hereford calves. Morantel tartrate is used in research related to gastrointestinal nematode infections .
loading...
    loading...
Cat. No.: HY-14495
CAS No.: 674343-47-6
Synonyms: EX-1314
Target:  

GHSR

Research Areas:  

Metabolic Disease

BMS-604992 (EX-1314) is a selective, orally active small-molecule growth hormone secretagogue receptor (GHSR) agonist. BMS-604992 demonstrates high-affinity binding (Ki=2.3 nM) and potent functional activity (EC50=0.4 nM). BMS-604992 can stimulate food intake in rodents .
loading...
    loading...
Cat. No.: HY-147927
CAS No.: 1802891-20-8
Target:  

Enteropeptidase

Research Areas:  

Metabolic Disease

Human enteropeptidase-IN-1 (compound 6b) is a highly potent, orally active and low systemic exposure enteropeptidase inhibitor. Human enteropeptidase-IN-1 boosts the increase in fecal protein output, and exhibits potent body weight loss in diet-induced obese (DIO) rat model. Human enteropeptidase-IN-1 can be used for anti-obesity research .
loading...
    loading...
Cat. No.: HY-173131
Target:  

5-HT Receptor

Research Areas:  

Others

5-HT4R agonist-2 (Compound 4) is a selective 5-HT4R agonist with an EC50 value of 0.41 nM. 5-HT4R agonist-2 can significantly enhance whole gut and colonic transit, increase fecal output and water content, while maintaining minimal systemic absorption, and it shows promise for the research of chronic idiopathic constipation .
loading...
    loading...
Cat. No.: HY-14495A
CAS No.: 760944-56-7
Synonyms: EX-1314 free base
Target:  

GHSR

Research Areas:  

Metabolic Disease

BMS-604992 (EX-1314) free base is a selective, orally active small-molecule growth hormone secretagogue receptor (GHSR) agonist. BMS-604992 free base demonstrates high-affinity binding (ki=2.3 nM) and potent functional activity (EC50=0.4 nM). BMS-604992 free base can stimulate food intake in rodents .
loading...
    loading...
Cat. No.: HY-14495B
CAS No.: 1469750-46-6
Synonyms: EX-1314 dihydrochloride
Target:  

GHSR

Research Areas:  

Metabolic Disease

BMS-604992 (EX-1314) dihydrochloride is a selective, orally active small-molecule growth hormone secretagogue receptor (GHSR) agonist. BMS-604992 dihydrochloride demonstrates high-affinity binding (ki=2.3 nM) and potent functional activity (EC50=0.4 nM). BMS-604992 dihydrochloride can stimulate food intake in rodents .
loading...
    loading...
Cat. No.: HY-147927A
CAS No.: 1802891-23-1
Target:  

Enteropeptidase

Research Areas:  

Metabolic Disease

(S)-Human enteropeptidase-IN-1 (Compound 6c) is an orally active enteropeptidase inhibitor with low systemic exposure (IC50 (initial): 26 nM; IC50 (app): 1.8 nM). (S)-Human enteropeptidase-IN-1 promotes increased fecal protein output and effectively reduces body weight in a diet-induced obese (DIO) rat model. (S)-Human enteropeptidase-IN-1 inhibits enteropeptidase via a reversible covalent mechanism and prolongs the enzyme inactivation time. (S)-Human enteropeptidase-IN-1 can be used in anti-obesity research .
loading...
    loading...
Cat. No.: HY-118935
CAS No.: 666256-06-0
Target:  

Adrenergic Receptor

Research Areas:  

Inflammation/Immunology

NGD9002 free base is a new generation of selective corticotropin-releasing factor-1 (CRF-1) receptor antagonist with inhibitory activity on CRF-induced colonic function stimulation. NGD9002 free base can reduce CRF-induced fecal output response and show an inhibitory IC50 value of 4.3 mg/kg. NGD9002 free base can effectively block CRF-induced colonic secretory motility stimulation at the highest dose and reduce acute water avoidance-induced defecation. NGD9002 free base can also prevent the occurrence of pain hypersensitivity reactions to repeated colonic distension .
loading...
    loading...
Cat. No.: HY-182340
CAS No.: 143394-68-7
Target:  

Adenosine Receptor

Research Areas:  

Endocrinology

KF20274 is an orally active adenosine A1 receptor antagonist. KF20274 increases the fecal pellet output in rats, and does not affect small intestinal propulsion or gastric emptying at defecation-increasing doses. KF20274 does not induce diarrhea at defecation-increasing doses. KF20274 can be used for the research of constipation .
loading...
    loading...